Advertisement

Hyperosmolar Solutions and Diuretics in the Treatment of Brain Edema

  • H. J. Klein
  • K. Schmidt

Abstract

Brain edema is the most common cause of increased intracranial pressure, whether restricted to a local area or occurring more diffusely. It is the uniform pathological reaction of brain tissue to disturbances of differing type and intensity. According to Klatzo [19] one must distinguish between a cytotoxic and a vasogenic edema. The questions regarding treatment of both types of edema are, therefore, naturally different. Cytotoxic edema results from a swelling of brain cells caused by a disturbance in energy supply, electrolyte regulation and inadequacy of the osmoregulating processes. Vasogenic brain edema is characterized by an increased vascular permeability and disturbances of the blood brain barrier (BBB) which lead to permeation of proteins and other serum contents into the extracellular space.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bürger, M (1925) Über Osmotherapie. Ther Gegenw 27:27–30, 72–75Google Scholar
  2. 2.
    Brown, FD, Hanlon, K, Mullan, SM (1978) Treatment of aneurysmal hemiplegia with dopamine and mannitol. J Neurosurg 49: 525–529PubMedCrossRefGoogle Scholar
  3. 3.
    Ferrer, E, Vila, F, Isamaat, F (1980) Mannitol response and histogram analysis in raised ICP. In: ICP IV, Springer, Berlin Heidelberg New York, pp 647–652Google Scholar
  4. 4.
    Gaab, M, Knoblich, OE, Schupp, J, Dietrich, K, Fuhrmeister, U, Gruss, P (1978) Wirkung unterschiedlicher Osmo- und Onkotherapie auf Hirndruck und elektrische Hirnaktivität beim experimentellen Hirnödem. Acta Neurochir 40, 203–221CrossRefGoogle Scholar
  5. 5.
    Gaab, M, Pflughaupt, KW, Ratzka, M, Wodarz, R, Gruss, P (1978) Critical intracranial effects of osmotherapy. Advances in Neurosurgery, vol 6. Springer, Berlin Heidelberg New York, pp 193–205Google Scholar
  6. 6.
    Gaab, M, Knoblich, OE, Schupp, J, Hermann, F, Fuhrmeister, U, Pflughaupt, KW (1979) Effects of frusemide (Lasix) on acute severe experimental cerebral edema. J Neurol 220, 185–192PubMedCrossRefGoogle Scholar
  7. 7.
    Gaab, M, Trost, HA, Haubitz, I, Pflughaupt, KW, Halves, E (1980) Osmoregulation, Brain damage and Prognosis. Advances in Neurosurgery, vol 8. Springer, Berlin Heidelberg New YorkGoogle Scholar
  8. 8.
    Gaab, M, Bushe, KA (1981) Die Behandlung der intrakraniellen Drucksteigerung. Intensivbehandlung 6: 1, 34–52Google Scholar
  9. 9.
    Goluboff, B, Shenkin, HA, Haft, H (1964) The effects of mannitol and urea on cerebral hemodynamics and cerebrospinal fluid pressure. Neurology (Minneap) 14, 891–898Google Scholar
  10. 10.
    Gottstein, U (1974) Behandlung der cerebralen Mangeldurchblutung. Internist 15, 575–587PubMedGoogle Scholar
  11. 11.
    Gottstein, U (1977) personal communicationGoogle Scholar
  12. 12.
    Hagemann, E (1920) Über osmotische Wirkungen intravenöser Zuckerinjektionen unter wechselnden Bedingungen. Zschr Ges Exp Med 11, 239–256CrossRefGoogle Scholar
  13. 13.
    Halmägyi, M (1970) Veränderungen des Wasser- und Elektrolythaushaltes durch Osmotherapie. Anaesthesiology and Resuscitation, vol 46, Springer, Berlin Heidelberg New YorkGoogle Scholar
  14. 14.
    Hase, U, Reulen, HJ (1980) Wirkung von Sorbit und Mannit auf den intrakraniellen Druck. Neurochirurgia 23, 205–211PubMedGoogle Scholar
  15. 15.
    Hermann, F, Gaab, M, Pflughaupt, KW, Gruss, P (1981) Medikamentöse Therapie beim experimentellen Hirnödem. Neurochirurgica 24, 39–46Google Scholar
  16. 16.
    Herrschaft, H (1976) Die Therapie der cerebralen Mangeldurchblutung. Der Nervenarzt 47, 639–650PubMedGoogle Scholar
  17. 17.
    James, HE (1980) Methodology for the control of intracranial pressure with hypertonic mannitol. In: ICP IV, Springer, Berlin Heidelberg New York, pp 653–655Google Scholar
  18. 18.
    James, HE, Harbaugh, RD, Marshall, LF, Shapiro, HM, Laurin, R (1980) The response to multiple therapeutic modalities in experimental vasogenic edema. In: ICP IV, Springer, Berlin Heidelberg New York, pp 272–276Google Scholar
  19. 18.
    Isfort, A (1966) Indikationen der Osmotherapie in der Neurochirurgie. In: Anaesthesiologie und Wiederbelebung. Bd. 13: Infusionstherapie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  20. 19.
    Klatzo, I, Wisniewski, H, Steinwall, O, Steicher, E (1967) Dynamics of cold injury edema. In: Brain edema. Klatzo, Seitelberger (eds). Springer, Berlin Heidelberg New York, pp 554–563Google Scholar
  21. 20.
    Klein, HJ (1980) Gedeckte Schädel-Hirn-Traumen. Notfallmedizin 6, 860–872Google Scholar
  22. 21.
    Klein, HJ (1982) Kontinuierliche Hirndruckregistrierung — Teil jeder Hirndrucktherapie? Klinikarzt 5, 520–527Google Scholar
  23. 22.
    Lanksch, W, Grumme, Th, Kazner, E (1978) Schädelhirnverletzungen im Computertomogramm. Springer, Berlin Heidelberg New YorkGoogle Scholar
  24. 23.
    Leech, P, Miller, JD (1975) The effect of mannitol, steroids and hypocapnia on the intracranial volume/pressure response. In: ICP II. Springer, Berlin Heidelberg New York, pp 301–364Google Scholar
  25. 24.
    Little, J (1978) Modification of acute focal ischemia by treatment with mannitol and high-dose dexamethasone. J Neurosurg 49, 517–524PubMedCrossRefGoogle Scholar
  26. 25.
    Meinig, G, Aulich, A, Wende, S, Reulen, HJ (1976) The effects of dexamethasone and diuretics on peritumor brain edema: Comparative study of tissue water content and CT. In: Dynamics of brain edema. Pappius, HM, Feindl, W (eds). Springer, Berlin Heidelberg New York, pp 301–305Google Scholar
  27. 26.
    Meinig, G (1980) Beurteilung der antiödematösen Therapie bei Hirntumorpatienten. Neurochirurgia 23, 212–218PubMedGoogle Scholar
  28. 27.
    Reulen, HJ (1965) Vor- und Nachteile der osmotischen Behandlung des Hirnödems. Zbl Neurochir 26: 4 /5, 232–249Google Scholar
  29. 28.
    Reulen, HJ, Medzihradsky, F, Enzenbach, R, Marguth, F, Brendel, W (1969) Electrolytes, fluids, and energy metabolism in human cerebral edema. Arch Neurol 21, 517–525PubMedGoogle Scholar
  30. 29.
    Reulen, HJ (1976) Vasogenic brain oedema. New aspects in its formation, resolution and therapy. Br J Anaesth 48: 741–752PubMedCrossRefGoogle Scholar
  31. 30.
    Reulen, HJ, Steude, U, Brendel, W, Hilber, C, Prusiner, S (1970) Energetische Störungen des Kationentransports als Ursache des intrazellulären Hirnödems. Acta Neurochir 22, 129–166CrossRefGoogle Scholar
  32. 31.
    Reulen, HJ, Schürmann, K (1981) Nonsurgical management of severe head injuries. Prog neurol Surg, vol 10, 291–322, Karger, BaselGoogle Scholar
  33. 32.
    Richard, KE (1980) Intrakranielle Drucksteigerung, ihre Pathogenese, Klinik und Behandlung. Nervenarzt 51, 392–405PubMedGoogle Scholar
  34. 33.
    Schmidt, K (1963) Zur Wirkung einiger Osmotherapeutika. Anaesthesist 12, 216–222PubMedGoogle Scholar
  35. 34.
    Schmidt, K (1966) Zur Behandlung von Hirndruck und Hirnödem in der Neurochirurgie und in der Unfallchirurgie durch Osmo- und Onkotherapie. Schlesw-Holst Ärztebl 18: 7Google Scholar
  36. 35.
    Schmidt, K (1966) Klinisch-experimentelle Grundlagen der Osmotherapie. In: Anaesthesiologie und Wiederbelebung, Bd. 13: Infusionstherapie. Springer, Berlin GöttingenGoogle Scholar
  37. 36.
    Schmidt, K, Schmalz, H (1967) Zur Blutvolumenänderung nach Osmo-Onko-Therapie. Anaesthesist 16: 201–204PubMedGoogle Scholar
  38. 37.
    Schmidt, K (1967) Zur Onkotherapie des Hirnödems mit Furosemid. Acta Neurochirurgica 17, 32PubMedCrossRefGoogle Scholar
  39. 38.
    Schmidt, K (1970) Einfluß der Plasmaviskositätsänderungen nach Osmo- und Onkotherapie auf die Hämodynamik. Anaesthesist 19, 146–152PubMedGoogle Scholar
  40. 39.
    Schmidt, K (1972) Hirndurchblutung bei intrakranieller Drucksteigerung und beim Hirn¬ödem. In: Der Hirnkreislauf. Physiologie-Pathologie-Klinik. Gänshirt H (ed). Thieme, StuttgartGoogle Scholar
  41. 40.
    Schultis, K, Gofferje, H, Brand, O (1976) Zur Osmotherapie im zentrogenen Schock. In Neurogener Schock. Schattauer, Stuttgart, pp 83–89Google Scholar
  42. 41.
    Shenkin, HA, Goluboff, B, Haft, H (1962) The use of mannitol for the reduction of ICP in intracranial surgery. J Neurosurg 19, 897–901PubMedCrossRefGoogle Scholar
  43. 42.
    Silber, SJ, Thompson, N (1972) Mannitol induced central nervous system toxicity in renal failure. Invest Urol 9, 310–312PubMedGoogle Scholar
  44. 43.
    Sklar, FH, Beyer, CW Jr, Ramanathan, M, Clark, WK (1980) The effects of frusemide on CSF dynamics in patients with pseudotumor cerebri. In: ICP IV. Springer, Berlin Heidelberg New York, pp 660–663Google Scholar
  45. 44.
    Tullis, JL (1977) Albumin 1. Background and Use. JAMA Vol 237: 4: 355–360PubMedCrossRefGoogle Scholar
  46. 45.
    Wise, BL, Chater, N (1962) The value of hypertonic mannitol solutions in decreasing brain mass and lowering cerebrospinal fluid pressure. J Neurosurg 19, 1038–1043PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1982

Authors and Affiliations

  • H. J. Klein
  • K. Schmidt

There are no affiliations available

Personalised recommendations